Clinical Trial Update: Early Versus Delayed Enteral Feeding and Omega-3 Fatty Acid/Antioxidant Supplementation for Treating People With Acute Lung Injury or Acute Respiratory Distress Syndrome (The EDEN-Omega Study) [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial update reports termination of the EDEN-Omega study evaluating early versus delayed enteral feeding with omega-3 fatty acid and antio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Injury
• Respiratory Distress Syndrome

Drugs mentioned

• Omega-3 fatty acid/antioxidant supplementation (omega-3 fatty acids; antioxidants)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Respiratory Distress Syndrome, Adult | Phase 3 | Status: TERMINATED